Gemini Therapeutics, Inc.

Informe acción NasdaqGM:GMTX

Capitalización de mercado: US$58.5m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Gemini Therapeutics Dirección

Dirección controles de criterios 1/4

Información clave

Georges Gemayel

Chief Executive Officer (CEO)

US$717.4k

Compensación total

Porcentaje del salario del CEO5.3%
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la dirección1.2yrs
Promedio de permanencia en la Junta Directiva2.7yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Georges Gemayel en comparación con los beneficios de Gemini Therapeutics?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2022n/an/a

-US$43m

Jun 30 2022n/an/a

-US$59m

Mar 31 2022n/an/a

-US$68m

Dec 31 2021US$717kUS$38k

-US$72m

Compensación vs. Mercado: Georges's total compensation ($USD717.44K) is about average for companies of similar size in the US market ($USD749.99K).

Compensación vs. Ingresos: Insufficient data to compare Georges's compensation with company performance.


CEO

Georges Gemayel (62 yo)

less than a year

Permanencia

US$717,436

Compensación

Dr. Georges Gemayel, Ph D.,CFA, serves as Director of GlycoEra AG since July 2022. He has been Executive Chairperson of Gemini Therapeutics, Inc. since November 2021 and has been its Interim President and...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Georges Gemayel
Interim President & CEO and Executive Chairpersonless than a yearUS$717.44ksin datos
Brian Piekos
Chief Business Officer1.8yrsUS$4.17m0%
$ 0
Jason Meyenburg
Advisorno dataUS$10.36m0%
$ 0
Patrick Truesdell
VP of Finance & Controller1.2yrssin datossin datos

1.2yrs

Permanencia media

45yo

Promedio de edad

Equipo directivo experimentado: GMTX's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Georges Gemayel
Interim President & CEO and Executive Chairperson1.6yrsUS$717.44ksin datos
Carl Gordon
Independent Director6.7yrsUS$78.55k0.040%
$ 23.3k
David Lubner
Independent Director2.7yrsUS$749.99k0%
$ 0
Jason Rhodes
Independent Director6.7yrsUS$74.67k0.040%
$ 23.3k
John Atkinson
Member of Scientific Advisory Boardno datasin datossin datos
Napoleone Ferrara
Member of Scientific Advisory Boardno datasin datossin datos
Tuyen Ong
Independent Director2.3yrsUS$750.00k0%
$ 0
Aravind Asokan
Member of Scientific Advisory Boardno datasin datossin datos
Dean Bok
Member of Scientific Advisory Boardno datasin datossin datos
Michael Ehrmann
Member of Scientific Advisory Boardno datasin datossin datos
Shannon Boye
Member of Scientific Advisory Boardno datasin datossin datos
Catherine Rickman
Member of Scientific Advisory Boardno datasin datossin datos

2.7yrs

Permanencia media

57.5yo

Promedio de edad

Junta con experiencia: GMTX's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.